Abstract
Objective: To analyze the clinical characteristics, predictive factors and curative effects of mycoplasma pneumoniae (MP) infection combined with pleural effusion in children.
Methods: The medical records of 200 children diagnosed with MP pneumonia in our hospital from January 2021 to December 2023 were retrospectively analyzed. According to the presence or absence of pleural effusion, all the children were divided into mycoplasma pneumoniae pneumonia (MPP) with pleural effusion group (100 cases) and MPP without pleural effusion group (100 cases). The differences in clinical manifestations, laboratory indicators, imaging examination, treatment plan and treatment effect between the two groups were compared. Multivariate Logistic regression model was used to analyze the potential predictors of MPP combined with pleural effusion.
Result: Age, length of hospital stay CRP level, white blood cell count, neutrophil count, IgM level, left lung disease, intravenous glucocorticoid use, duration of fever during hospitalization and duration of antibiotic use in MPP group were higher than those in group without pleural effusion (P<0.05). The number of cases, bilateral lung lesions and IgA levels in autumn were significantly lower than those in the group without pleural effusion (P<0.05). Multivariate Logistic regression analysis showed that age, CRP, white blood cell count, autumn infection, IgM and IgA levels were correlated with pleural effusion.
Conclusions: The predictors of MP infection with pleural effusion in children include age, CRP, WBC, autumn infection, IgM and IgA. These factors may contribute to the early identification and treatment of children with MP pneumonia combined with pleural effusion.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.